Cytosorbents News

B. Riley Securities Reiterates Buy on CytoSorbents, Maintains $3 Price Target

B. Riley Securities analyst Yuan Zhi reiterates CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $3 price target.

BenzingaMay 15 10:06 ET

Cytosorbents First Quarter 2024 Earnings: In Line With Expectations

Yahoo FinanceMay 12 09:03 ET

Earnings Call Summary | Cytosorbents(CTSO.US) Q1 2024 Earnings Conference

The following is a summary of the Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript:Financial Performance:Cytosorbents Corporation experienced a 14% increase in product sales in Q1 2024

moomoo AIMay 10 09:57 ET · Conference Call

CytoSorbents Q1 2024 GAAP EPS $(0.12), Inline, Sales $9.787M Beat $9.785M Estimate

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 29.41 percent increase over losses of $(0.17) per share from the same peri

BenzingaMay 9 17:19 ET

Cytosorbents | 10-Q: Quarterly report

Futu NewsMay 9 17:02 ET · Announcements

CytoSorbents: Q1 Earnings Snapshot

BarchartMay 9 16:24 ET

Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, Vs. Street Est of $9.79M

04:18 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M

MT NewswiresMay 9 16:18 ET

Express News | Cytosorbents Reports First Quarter 2024 Results

ReutersMay 9 16:17 ET

Express News | Cytosorbents Q1 Revenue USD 8.965 Million

ReutersMay 9 16:17 ET

Express News | Cytosorbents Q1 Product Gross Margin 76%

ReutersMay 9 16:17 ET

Express News | Cytosorbents Q1 EPS USD -0.12

ReutersMay 9 16:17 ET

Cytosorbents 1Q Rev $9.79M >CTSO

Cytosorbents 1Q Rev $9.79M >CTSO

Dow JonesMay 9 16:17 ET

Cytosorbents 1Q Loss $6.36M >CTSO

Cytosorbents 1Q Loss $6.36M >CTSO

Dow JonesMay 9 16:17 ET

Hold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical Results

TipRanksMay 7 07:46 ET

CytoSorbents Executives Take Pay Cuts for Stock Options

TipRanksApr 3 06:24 ET

Cytosorbents Full Year 2023 Earnings: Misses Expectations

Yahoo FinanceMar 16 08:20 ET

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 15 10:14 ET

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.

Analyst UpgradesMar 15 06:40 ET

Cytosorbents Financial and Clinical Study Outlook: Maintaining a Hold Rating

TipRanksMar 15 06:27 ET

Earnings Call Summary | Cytosorbents(CTSO.US) Q4 2023 Earnings Conference

The following is a summary of the CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript:Financial Performance:CytoSorbents Corporation reported a revenue of $36.3 million for the year, a 5%

moomoo AIMar 15 00:59 ET · Conference Call